Companion Diagnostics Market by Indication (Oncology (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, and Gastric Cancer), Cardiovascular Diseases, Central Nervous System Disorders, Inflammation and Virology Diseases), by Technology (Immunohistochemistry, Molecular Diagnostics (In-Situ Hybridization, Real Time PCR and Gene Sequencing) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Companion Diagnostics Market by Indication (Oncology (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, and Gastric Cancer), Cardiovascular Diseases, Central Nervous System Disorders, Inflammation and Virology Diseases), by Technology (Immunohistochemistry, Molecular Diagnostics (In-Situ Hybridization, Real Time PCR and Gene Sequencing) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 640 | Pages: 178 | October 2016 | Region: Global


The Global Companion Diagnostics Market was worth $3.34 billion in 2016 and estimated to be growing at a CAGR of 21.6%, to reach $8.88 billion by 2021. Companion diagnostics is categorized by rising requirement for improved personalized patient treatment that contributes healthcare providers and their patients an assurance about the treatment result in a positive way, differing from traditional treatment procedure.

Companion diagnostic are used to regulate patient personal molecular profile which supports in determining which therapy will work for the patient. This diagnostic procedure requires a biopsied tissue to contact the appearance of biomarker protein or mutant. Companion diagnostics are also used in drug development process by defining Companion biomarker that helps foresee likely response of toxicity.  

Key factors boosting the market growth are increasing adoption of companion diagnostic tests, encouragement from regulatory bodies and emerging advanced technologies such as next-generation sequencing (NGS). To seizure this market, pharmaceutical companies are motivated to enter into the global market through strategic achievements and alliances with NGS platform diagnostic firms. Companion diagnostic market growth is hampered due to lack of skilled professionals and lack of awareness.

The global clinical nutrition market is segmented on the basis of indication into Oncology (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, and Gastric Cancer), Cardiovascular Diseases, Central Nervous System Disorders, Inflammation and Virology Diseases. Further, Oncology is sub-segmented as Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, and Gastric Cancer. Oncology being the highest revenue creating segment as most of the companion diagnostics has been developed to detect one or the other cancer biomarkers. On the basis of technology, the market is bifurcated into Immunohistochemistry and molecular diagnostics. Molecular diagnostics is segmented into in-situ hybridization, real time PCR and gene sequencing.

Based on geography the market is analysed under various regions namely, North America, Latin America, Europe, Asia-Pacific and Middle-East & Africa. Due to technical advancement and huge investment on research & development, North America is leading the companion diagnostic market. While Europe and Asia-Pacific are expected to grow at significant growth rate.

Some of the key participating global players in companion diagnostics market global market are Abbott Molecular Inc., Roche Molecular Systems Inc., Leica Biosystems Nussloch GmbH, bioMérieux Inc., Dako Inc., Qiagen Ltd., ARUP Laboratories, Myriad Genetics Inc.,Biogenex Laboratories Inc., Ventana Medical Systems Inc., Thermo Fisher Scientific Inc. and others.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Indications                            

                                5.1.1 Oncology 

                                                5.1.1.1 Colorectal Cancer

                                                5.1.1.2 Breast Cancer

                                                5.1.1.3 Lung Cancer

                                                5.1.1.4 Gastric Cancer

                                                5.1.1.5 Melanoma

                                5.1.2 Inflammation and Autoimmune Diseases  

                                5.1.3 Cardiovascular Diseases    

                                5.1.4 Central Nervous System Disorders               

                                5.1.5 Virology Diseases 

                5.2 By Technology                           

                                5.2.1 Immuno Histochemistry    

                                5.2.2 Molecular Diagnostics        

                                                5.2.2.1 In-Situ Hybridization

                                                5.2.2.2 Real Time PCR

                                                5.2.2.3 Gene Sequencing

6. Geographical Analysis                                              

                6.1 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.2 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.3 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 South Korea           

                                6.3.6 Australia   

                6.4 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Mexico     

                                6.4.4 Argentina

                                6.4.5 Rest of Latin America          

                6.5 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Abbott Molecular Inc.                            

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Roche Molecular Systems Inc.                            

                8.3 Leica Biosystems Nussloch GmbH                     

                8.4 BioMérieux Inc.                        

                8.5 Dako Inc.                     

                8.6 Qiagen Ltd.                 

                8.7 ARUP Laboratories                  

                8.8 Myriad Genetics Inc.                              

                8.9 Biogenex Laboratories, Inc.                 

                8.10 Ventana Medical Systems Inc.                         

                8.11 Thermo Fisher Scientific Inc.                             

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

TitlePriceAdd To Cart
  1. Global Companion Diagnostics Market By Region, From 2016-2021 (USD Billion)
  2. Global Companion Diagnostics Market By Indication, From 2016-2021 (USD Billion)
  3. Global Oncology Market By Region, From 2016-2021 (USD Billion)
  4. Global Inflammation and Autoimmune Diseases Market By Region, From 2016-2021 (USD Billion)
  5. Global Cardiovascular Diseases Market By Region, From 2016-2021 (USD Billion)
  6. Global Central Nervous System Disorders Market By Region, From 2016-2021 (USD Billion)
  7. Global Virology Diseases Market By Region, From 2016-2021 (USD Billion)
  8. Global Companion Diagnostics Market By Technology, From 2016-2021 (USD Billion)
  9. Global Immuno Histochemistry Market By Region, From 2016-2021 (USD Billion)
  10. Global Molecular Diagnostics Market By Region, From 2016-2021 (USD Billion)
  11. Global Oncology Diagnostics Market By Type, From 2016-2021 (USD Billion)
  12. Global Colorectal Cancer Diagnostics Market By Region, From 2016-2021 (USD Billion)
  13. Global Breast Cancer Diagnostics Market By Region, From 2016-2021 (USD Billion)
  14. Global Lung Cancer Diagnostics Market By Region, From 2016-2021 (USD Billion)
  15. Global Gastric Cancer Diagnostics Market By Region, From 2016-2021 (USD Billion)
  16. Global Melanoma Diagnostics Market By Region, From 2016-2021 (USD Billion)
  17. Global Molecular Diagnostics Market By Type, From 2016-2021 (USD Billion)
  18. Global In-Situ Hybridization Market By Region, From 2016-2021 (USD Billion)
  19. Global Real Time PCR Market By Region, From 2016-2021 (USD Billion)
  20. Global Gene Sequencing Market By Region, From 2016-2021 (USD Billion)
  21. North America Companion Diagnostics Market By Region, From 2016-2021 (USD Billion)
  22. North America Companion Diagnostics Market By Indication, From 2016-2021 (USD Billion)
  23. North America Companion Diagnostics Market By Technology, From 2016-2021 (USD Billion)
  24. North America Oncology Diagnostics Market By Type, From 2016-2021 (USD Billion)
  25. North America Molecular Diagnostics Market By Type, From 2016-2021 (USD Billion)
  26. United States Companion Diagnostics Market By Indication, From 2016-2021 (USD Billion)
  27. United States Companion Diagnostics Market By Technology, From 2016-2021 (USD Billion)
  28. United States Oncology Diagnostics Market By Type, From 2016-2021 (USD Billion)
  29. United States Molecular Diagnostics Market By Type, From 2016-2021 (USD Billion)
  30. Canada Companion Diagnostics Market By Indication, From 2016-2021 (USD Billion)
  31. Canada Companion Diagnostics Market By Technology, From 2016-2021 (USD Billion)
  32. Canada Oncology Diagnostics Market By Type, From 2016-2021 (USD Billion)
  33. Canada Molecular Diagnostics Market By Type, From 2016-2021 (USD Billion)
  34. Europe Companion Diagnostics Market By Region, From 2016-2021 (USD Billion)
  35. Europe Companion Diagnostics Market By Indication, From 2016-2021 (USD Billion)
  36. Europe Companion Diagnostics Market By Technology, From 2016-2021 (USD Billion)
  37. Europe Oncology Diagnostics Market By Type, From 2016-2021 (USD Billion)
  38. Europe Molecular Diagnostics Market By Type, From 2016-2021 (USD Billion)
  39. U.K Companion Diagnostics Market By Indication, From 2016-2021 (USD Billion)
  40. U.K Companion Diagnostics Market By Technology, From 2016-2021 (USD Billion)
  41. U.K Oncology Diagnostics Market By Type, From 2016-2021 (USD Billion)
  42. U.K Molecular Diagnostics Market By Type, From 2016-2021 (USD Billion)
  43. Spain Companion Diagnostics Market By Indication, From 2016-2021 (USD Billion)
  44. Spain Companion Diagnostics Market By Technology, From 2016-2021 (USD Billion)
  45. Spain Oncology Diagnostics Market By Type, From 2016-2021 (USD Billion)
  46. Spain Molecular Diagnostics Market By Type, From 2016-2021 (USD Billion)
  47. Germany Companion Diagnostics Market By Indication, From 2016-2021 (USD Billion)
  48. Germany Companion Diagnostics Market By Technology, From 2016-2021 (USD Billion)
  49. Germany Oncology Diagnostics Market By Type, From 2016-2021 (USD Billion)
  50. Germany Molecular Diagnostics Market By Type, From 2016-2021 (USD Billion)
  51. Italy Companion Diagnostics Market By Indication, From 2016-2021 (USD Billion)
  52. Italy Companion Diagnostics Market By Technology, From 2016-2021 (USD Billion)
  53. Italy Oncology Diagnostics Market By Type, From 2016-2021 (USD Billion)
  54. Italy Molecular Diagnostics Market By Type, From 2016-2021 (USD Billion)
  55. France Companion Diagnostics Market By Indication, From 2016-2021 (USD Billion)
  56. France Companion Diagnostics Market By Technology, From 2016-2021 (USD Billion)
  57. France Oncology Diagnostics Market By Type, From 2016-2021 (USD Billion)
  58. France Molecular Diagnostics Market By Type, From 2016-2021 (USD Billion)
  59. Asia-Pacific Companion Diagnostics Market By Region, From 2016-2021 (USD Billion)
  60. Asia-Pacific Companion Diagnostics Market By Indication, From 2016-2021 (USD Billion)
  61. Asia-Pacific Companion Diagnostics Market By Technology, From 2016-2021 (USD Billion)
  62. Asia-Pacific Oncology Diagnostics Market By Type, From 2016-2021 (USD Billion)
  63. Asia-Pacific Molecular Diagnostics Market By Type, From 2016-2021 (USD Billion)
  64. China Companion Diagnostics Market By Indication, From 2016-2021 (USD Billion)
  65. China Companion Diagnostics Market By Technology, From 2016-2021 (USD Billion)
  66. China Oncology Diagnostics Market By Type, From 2016-2021 (USD Billion)
  67. China Molecular Diagnostics Market By Type, From 2016-2021 (USD Billion)
  68. India Companion Diagnostics Market By Indication, From 2016-2021 (USD Billion)
  69. India Companion Diagnostics Market By Technology, From 2016-2021 (USD Billion)
  70. India Oncology Diagnostics Market By Type, From 2016-2021 (USD Billion)
  71. India Molecular Diagnostics Market By Type, From 2016-2021 (USD Billion)
  72. Japan Companion Diagnostics Market By Indication, From 2016-2021 (USD Billion)
  73. Japan Companion Diagnostics Market By Technology, From 2016-2021 (USD Billion)
  74. Japan Oncology Diagnostics Market By Type, From 2016-2021 (USD Billion)
  75. Japan Molecular Diagnostics Market By Type, From 2016-2021 (USD Billion)
  76. South Korea Companion Diagnostics Market By Indication, From 2016-2021 (USD Billion)
  77. South Korea Companion Diagnostics Market By Technology, From 2016-2021 (USD Billion)
  78. South Korea Oncology Diagnostics Market By Type, From 2016-2021 (USD Billion)
  79. South Korea Molecular Diagnostics Market By Type, From 2016-2021 (USD Billion)
  80. Australia Companion Diagnostics Market By Indication, From 2016-2021 (USD Billion)
  81. Australia Companion Diagnostics Market By Technology, From 2016-2021 (USD Billion)
  82. Australia Oncology Diagnostics Market By Type, From 2016-2021 (USD Billion)
  83. Australia Molecular Diagnostics Market By Type, From 2016-2021 (USD Billion)
  84. Latin America Companion Diagnostics Market By Region, From 2016-2021 (USD Billion)
  85. Latin America Companion Diagnostics Market By Indication, From 2016-2021 (USD Billion)
  86. Latin America Companion Diagnostics Market By Technology, From 2016-2021 (USD Billion)
  87. Latin America Oncology Diagnostics Market By Type, From 2016-2021 (USD Billion)
  88. Latin America Molecular Diagnostics Market By Type, From 2016-2021 (USD Billion)
  89. Brazil Companion Diagnostics Market By Indication, From 2016-2021 (USD Billion)
  90. Brazil Companion Diagnostics Market By Technology, From 2016-2021 (USD Billion)
  91. Brazil Oncology Diagnostics Market By Type, From 2016-2021 (USD Billion)
  92. Brazil Molecular Diagnostics Market By Type, From 2016-2021 (USD Billion)
  93. Argentina Companion Diagnostics Market By Indication, From 2016-2021 (USD Billion)
  94. Argentina Companion Diagnostics Market By Technology, From 2016-2021 (USD Billion)
  95. Argentina Oncology Diagnostics Market By Type, From 2016-2021 (USD Billion)
  96. Argentina Molecular Diagnostics Market By Type, From 2016-2021 (USD Billion)
  97. Mexico Companion Diagnostics Market By Indication, From 2016-2021 (USD Billion)
  98. Mexico Companion Diagnostics Market By Technology, From 2016-2021 (USD Billion)
  99. Mexico Oncology Diagnostics Market By Type, From 2016-2021 (USD Billion)
  100. Mexico Molecular Diagnostics Market By Type, From 2016-2021 (USD Billion)
  101. Middle East & Africa Companion Diagnostics Market By Region, From 2016-2021 (USD Billion)
  102. Middle East & Africa Companion Diagnostics Market By Indication, From 2016-2021 (USD Billion)
  103. Middle East & Africa Companion Diagnostics Market By Technology, From 2016-2021 (USD Billion)
  104. Middle East & Africa Oncology Diagnostics Market By Type, From 2016-2021 (USD Billion)
  105. Middle East & Africa Molecular Diagnostics Market By Type, From 2016-2021 (USD Billion)
  106. Middle East Companion Diagnostics Market By Indication, From 2016-2021 (USD Billion)
  107. Middle East Companion Diagnostics Market By Technology, From 2016-2021 (USD Billion)
  108. Middle East Oncology Diagnostics Market By Type, From 2016-2021 (USD Billion)
  109. Middle East Molecular Diagnostics Market By Type, From 2016-2021 (USD Billion)
  110. Africa Companion Diagnostics Market By Indication, From 2016-2021 (USD Billion)
  111. Africa Companion Diagnostics Market By Technology, From 2016-2021 (USD Billion)
  112. Africa Oncology Diagnostics Market By Type, From 2016-2021 (USD Billion)
  113. Africa Molecular Diagnostics Market By Type, From 2016-2021 (USD Billion)

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, kakatiya's empire,
Jubilee Gardens,
Hyderabad, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.